As of January this year, California, New Hampshire, Pennsylvania and South Carolina ended Medicaid GLP-1 drug coverage for weight loss, and Michigan started restricting coverage to people classified as morbidly obese, meaning they have a body mass index above 40
Hypoglycaemia risk is generally low in non-diabetic individuals but warrants attention in those on concomitant antidiabetic medications
if vomiting or dehydration is significant, contact your service before taking the next dose
Before we get into cost, it helps to know what youre paying for
Many doctors will consider continuing weight loss medication if youve achieved significant results, and stopping treatment might lead to weight regain
Syringes and needles are allowed when traveling with a needle-using medication like tirzepatide